Knowing the results of psychedelics on human brain networks is critical to unlocking their therapeutic mechanisms. In individuals, in the about 6 hour duration of motion, psilocybin boosts glutamate signalling and glucose metabolism19,20,21, broadly decreases the strength of electrophysiological signals22, lessens hemodynamic fluctuations23 and d